Is Bayer AG halal to invest in?

As of August 2026, Bayer AG BAYN.VI is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Bayer AG a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Bayer AG using these criteria to determine its compliance status.

Can Muslims buy shares of Bayer AG?

Muslim investors may consider investing in Bayer AG if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Bayer AG classified as NOT HALAL?

Musaffa determines the Shariah status of Bayer AG by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Bayer AG updated?

The Shariah compliance status of Bayer AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Bayer AG become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Bayer AG?

You can check the latest Shariah compliance status of Bayer AG on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Bayer AG BAYN.VI

Last Updated: Aug 07, 12:00 AM·WBAG

BAYN.VI Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, Bayer AG is classified as not halal.

NOT HALAL

Report Source: undefined Quarter Report

Bayer AG. Stock Analysis BAYN.VI

Austria Health Care Large Cap

Bayer AG engages in the business of life science fields of healthcare and nutrition. The company is headquartered in Leverkusen, Nordrhein-Westfalen and currently employs 88,078 full-time employees. The firm's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.